TIDMSMD

RNS Number : 2557B

Spectral MD Holdings, Ltd.

01 June 2023

Spectral MD Holdings, Ltd

("Spectral MD" or the "Company")

Block Listing Six Monthly Return

LONDON, U.K. AND DALLAS, TX, U.S -Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, provides the following information in connection with its block admissions pursuant to AIM Rule 29 and Schedule Six of the AIM Rules for Companies:

 
 Name of applicant:                             Spectral MD Holdings, Ltd. 
 Name of scheme:                                2018 Long-Term Incentive Plan 
                                               ---------------------------------- 
 Period of return:                  From:       8 November     To:    7 May 2023 
                                                 2022 
                                   ----------  -------------  -----  ------------ 
 Balance of unallotted securities               2,000,000 Ordinary shares 
  under scheme(s) from previous 
  return: 
                                               ---------------------------------- 
 Plus: The amount by which the                  - 
  block scheme(s) has been increased 
  since the date of the last return 
  (if any increase has been applied 
  for): 
                                               ---------------------------------- 
 Less: Number of securities issued/allotted     104,451 Ordinary shares 
  under scheme(s) during period: 
                                               ---------------------------------- 
 Equals: Balance under scheme(s)                1,895,549 Ordinary shares 
  not yet issued/allotted at end 
  of period: 
                                               ---------------------------------- 
 
 
 
 Name of contact:                Vince Capone, General Counsel/Corporate 
                                  Secretary 
 Telephone number of contact:    +1 972 499-4934 
                                ----------------------------------------

For further information please contact:

 
 Spectral MD Holdings, Ltd. 
 Wensheng Fan, Chief Executive Officer                                     IR@Spectralmd.com 
  Nils Windler, Chief Financial Officer                                      via Walbrook PR 
 
 SP Angel Corporate Finance LLP (NOMAD and Joint Broker for Spectral MD) 
 Stuart Gledhill / Harry Davies-Ball (Corporate Finance)            Tel: +44 (0)20 3470 0470 
  Vadim Alexandre / Rob Rees (Sales & Broking) 
 
 The Equity Group Inc. (US Investor Relations) 
 Devin Sullivan                                                       dsullivan@equityny.com 
                                                                           Tel: 212-836-9608 
 
 Walbrook PR Ltd (UK Media & Investor Relations) 
 Paul McManus / Louis Ashe-Jepson /Alice Woodings                  spectralMD@walbrookpr.com 
                                                                    Tel: +44 (0)20 7933 8780

About Spectral MD

Spectral MD is a predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care for burn, DFU, and future clinical applications. At Spectral MD, we are a dedicated team of forward-thinkers striving to revolutionize the management of wound care by "Seeing the Unknown"(R) with our DeepView(R) Wound Diagnostics System. The Company's DeepView(R) platform is the only predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. With algorithm-driven results that substantially exceed the current standard of care, Spectral MD's diagnostic platform is expected to provide faster and more accurate treatment insight, significantly improving patient care and clinical outcomes. For more information, visit the Company at: www.spectralmd.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLRNKDBBCBKDPPN

(END) Dow Jones Newswires

June 01, 2023 02:00 ET (06:00 GMT)

Spectral Md (LSE:SMD)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Spectral Md.
Spectral Md (LSE:SMD)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Spectral Md.